The NGAL Test – first diagnostic acute kidney injury biomarker which can be measured in both human urine and plasma.The NGAL Test is a particle-enhanced turbidimetric immunoassay for the quantitative determination of neutrophil gelatinase-associated lipocalin (NGAL) on automated clinical chemistry analyzers. NGAL measurements are useful in the diagnosis of acute kidney injury which may lead to acute renal failure.
At BioPorto Diagnostics, we know the critical value of reliability and consistency in research as in medical care of patients. Immonuassays from BioPorto are developed with this in mind and our offering consist of unique solutions for diagnostic companies as well as Health Care Professionals.BUY ONLINE
On a continued basis, we offer new high specificity monoclonal antibodies for pharmaceutical research and for developing diagnostic immunoassays kits. We have unique antibodies in areas such as diabetes and obesity, allergy and immune deficiency.BUY ONLINE